Assignee profile:

HEXAL AG

City:

Holzkirchen

Country:

Germany

Published Applications:

33

Last publication date:

2024-02-15

Patent Grants:

23

Last grant date:

2021-09-21

Top Inventors for applications by HEXAL AG

These are the the leading inventors for applications assigned to HEXAL AG:

Recent patent applications by HEXAL AG

HEXAL AG based in Holzkirchen, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-02-15
US20240052030A1
Chemistry; metallurgy

NOVEL FORMULATIONS FOR ANTIBODIES

#2 | 2020-03-26
US20200093821A1
Human necessities

Pharmaceutical Compositions of a Benzothiophene Compound

#3 | 2020-03-05 ✅ Patent 11,123,300 granted on 2021-09-21
US20200069593A1
Human necessities

Immediate release tablet of a benzothiophene compound

#4 | 2020-02-20 ✅ Patent 11,021,530 granted on 2021-06-01
US20200055923A1
Chemistry; metallurgy

Antibody preparation

#5 | 2019-12-26 ✅ Patent 11,072,605 granted on 2021-07-27
US20190389847A1
Chemistry; metallurgy

Crystalline brexpiprazole

#6 | 2019-06-13
US20190177385A1
Chemistry; metallurgy

GLYCOPROTEIN WITH REDUCED ACETYLATION RATE OF SIALIC ACID RESIDUES

#7 | 2019-02-14 ✅ Patent 10,501,450 granted on 2019-12-10
US20190047994A1
Chemistry; metallurgy

Anhydrate-free polymorphically pure micronized crystalline brexpiprazole di-hydrate for use in intramuscular injectable sustained release formulations

#8 | 2019-01-24
US20190025323A1
Physics

Methods of Mapping Protein Variants

#9 | 2018-08-30 ✅ Patent 10,668,073 granted on 2020-06-02
US20180243310A1
Human necessities

Pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereof

#10 | 2018-05-17 ✅ Patent 10,548,848 granted on 2020-02-04
US20180133160A1
Human necessities

Alogliptin formulation

#11 | 2017-11-23
US20170333424A1
Human necessities

Amorphous Vortioxetine Hydrobromide

#12 | 2017-09-07 ✅ Patent 10,732,162 granted on 2020-08-04
US20170254791A1
Physics

Method and device for determining the disintegration time of film-shaped pharmaceutical dosage forms

#13 | 2017-07-20
US20170205423A1
Physics

Method of Mapping Glycans of Glycoproteins in Serum Samples

#14 | 2017-06-29 ✅ Patent 10,335,443 granted on 2019-07-02
US20170182105A1
Human necessities

Orodispersible film

#15 | 2017-06-29 ✅ Patent 10,485,799 granted on 2019-11-26
US20170182034A1
Human necessities

Pharmaceutical composition of vortioxetine hydrobromide comprising vortioxetine hydrobromide in a polyethylene oxide matrix

#16 | 2016-09-29 ✅ Patent 9,789,112 granted on 2017-10-17
US20160279134A1
Human necessities

Oral pharmaceutical film formulation for bitter tasting drugs

#17 | 2016-01-21
US20160018409A1
Physics

IMPROVED METHOD OF MAPPING GLYCANS OF GLYCOPROTEINS

#18 | 2014-11-06 ✅ Patent 9,717,707 granted on 2017-08-01
US20140328936A1
Human necessities

Pharmaceutical statin composition

#19 | 2014-10-30 ✅ Patent 9,895,497 granted on 2018-02-20
US20140323986A1
Human necessities

Method for reducing leachables and extractables in syringes

#20 | 2014-08-14 ✅ Patent 9,592,296 granted on 2017-03-14
US20140227355A1
Human necessities

Pharmaceutical composition for oral administration with a statin

#21 | 2014-05-29 ✅ Patent 8,785,431 granted on 2014-07-22
US20140147477A1
Chemistry; metallurgy

Prodrugs of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their use in transdermal therapeutic systems

#22 | 2013-12-19 ✅ Patent 9,480,743 granted on 2016-11-01
US20130336968A1
Human necessities

Pharmaceutical formulation comprising a biopharmaceutical drug

#23 | 2013-12-12 ✅ Patent 9,844,515 granted on 2017-12-19
US20130331803A1
Human necessities

Transdermal therapeutic system comprising buprenorphine

#24 | 2013-08-22
US20130217697A1
Human necessities

ORAL PHARMACEUTICAL FILM FORMULATION FOR BITTER TASTING DRUGS

#25 | 2013-08-22
US20130216594A1
Human necessities

PREPARATION OF ORODISPERSIBLE FILMS

#26 | 2013-08-06 ✅ Patent 8,501,056 granted on 2013-08-06
US10479114
-

Homogenized product for implants and microparticles

#27 | 2012-08-30 ✅ Patent 9,211,265 granted on 2015-12-15
US20120220628A1
Human necessities

Tablets comprising a taste masking agent

#28 | 2012-06-14
US20120149713A1
Human necessities

ORAL FILMS COMPRISING 7-[4-[4-(2,3-DICHLOROPHENYL) PIPERAZIN-1-L]BUTOXY]-3,4-DIHYDRO-1H-QUINOLIN-2-ONE BASE OR SALTS OR HYDRATES THEREOF

#29 | 2011-08-04 ✅ Patent 8,720,165 granted on 2014-05-13
US20110190711A1
Human necessities

Method for reducing leachables and extractables in syringes

#30 | 2008-03-18 ✅ Patent 7,344,733 granted on 2008-03-18
US10484876
-

Matrix controlled transdermal therapeutic system for the use of pramipexole and ropinirole

#31 | 2008-01-17 ✅ Patent 7,690,494 granted on 2010-04-06
US20080014032A1
Performing operations; transporting

Conveyor device having a filling device for vertical flow of material, without demixing, of powdered media

#32 | 2007-05-22 ✅ Patent 7,220,473 granted on 2007-05-22
US10433373
-

Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic system

#33 | 2006-07-06 ✅ Patent 8,722,090 granted on 2014-05-13
US20060147529A1
Human necessities

Granulate comprising an oily substance, corresponding production method and tablet

Also check out HEXAL AG's (Holzkirchen, Germany) applicant profile with 10 patent applications submitted.

AssigneeID:

35864 ⎘